ATR and cystic fibrosis: First, the mechanism of action for ATR-002 and the basis for ATR-002 resistance in some CF clinical isolates of S. aureus are incompletely understood, and it is possible that the microbiologic effect of ATR-002 is transient with a limited therapeutic potential in vivo.